Company Information

Five-year assets, liabilities and shareholders’ funds.

Balance Sheet

SHREE GANESH REMEDIES LTD.

NSE Code: SGRLEQ
BSE Code: 540737
ISIN: INE414Y01015
Industry: Pharmaceuticals

Financial Data

Balance Sheet

All amounts are in ₹ crore unless stated otherwise.

Showing Standalone data

Five-year standalone Balance Sheet for the selected company
Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	128.38	128.38	128.47	128.47	120.07

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	12.84	12.84	12.84	12.51	12.01
Total Share Capital	12.84	12.84	12.84	12.51	12.01

Reserves and Surplus	150.18	132.36	109.26	76.43	49.57
Total Reserves and Surplus	150.18	132.36	109.26	76.43	49.57
Total Shareholders Funds	163.02	145.19	122.11	88.94	61.57

NON-CURRENT LIABILITIES
Long Term Borrowings	21.25	29.48	29.12	30.93	0.00
Deferred Tax Liabilities [Net]	1.08	0.53	0.58	0.00	0.20
Other Long Term Liabilities	0.13	0.13	0.12	0.00	0.00
Long Term Provisions	0.57	0.46	0.33	0.22	0.20
Total Non-Current Liabilities	23.03	30.60	30.16	31.16	0.40

CURRENT LIABILITIES
Short Term Borrowings	9.42	8.76	7.19	2.58	0.00
Trade Payables	9.44	5.97	8.19	14.53	9.47
Other Current Liabilities	2.79	1.43	3.28	5.85	4.65
Short Term Provisions	0.04	0.03	0.02	0.78	0.92
Total Current Liabilities	21.69	16.18	18.68	23.74	15.04

Total Capital And Liabilities	207.74	191.98	170.94	143.83	77.02

ASSETS
NON-CURRENT ASSETS
Tangible Assets	104.63	94.97	80.48	34.68	26.72
Intangible Assets	0.03	0.04	0.07	0.55	0.47
Capital Work-In-Progress	12.38	8.34	16.63	41.77	3.09
Intangible Assets Under Development	0.49	0.43	0.29	0.00	0.00
Fixed Assets	117.52	103.78	97.47	76.99	30.29
Non-Current Investments	0.16	0.16	0.16	0.08	0.08
Deferred Tax Assets [Net]	0.00	0.00	0.00	0.08	0.00
Other Non-Current Assets	4.22	10.50	3.18	1.36	1.74
Total Non-Current Assets	121.91	114.45	100.82	78.52	32.11


CURRENT ASSETS
Current Investments	12.45	18.26	4.66	0.00	0.00
Inventories	24.01	22.02	24.99	18.18	13.64
Trade Receivables	32.57	22.27	20.33	27.92	18.38
Cash And Cash Equivalents	13.45	9.99	16.19	11.15	3.88
Short Term Loans And Advances	0.00	0.00	0.00	2.01	5.07
OtherCurrentAssets	3.36	5.00	3.96	6.06	3.93
Total Current Assets	85.83	77.53	70.13	65.32	44.91

Total Assets	207.74	191.98	170.94	143.83	77.02

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	1.66	5.21	4.97	4.17	0.00

BONUS DETAILS
Bonus Equity Share Capital	3.03	3.03	3.04	3.04	3.04

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.16	0.16	0.16	0.08	0.08

CURRENT INVESTMENTS
Current Investments Quoted Market Value	12.45	18.26	4.66	0.00	0.00

Five-year consolidated Balance Sheet for the selected company
Particulars	Mar 26	Mar 25	Mar 24	Mar 20	Mar 19
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	128.38	128.38	128.47	89.71	89.71

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	12.84	12.84	12.84	8.97	8.97
Total Share Capital	12.84	12.84	12.84	8.97	8.97

Reserves and Surplus	150.13	132.32	109.26	33.23	24.85
Total Reserves and Surplus	150.13	132.32	109.26	33.23	24.85
Total Shareholders Funds	162.97	145.16	122.10	42.20	33.82
Minority Interest	0.00	0.00	0.00	0.04	0.00

NON-CURRENT LIABILITIES
Long Term Borrowings	21.25	29.48	29.12	2.20	0.24
Deferred Tax Liabilities [Net]	1.08	0.53	0.58	0.28	0.33
Other Long Term Liabilities	0.13	0.13	0.12	0.00	0.00
Long Term Provisions	0.57	0.46	0.33	0.18	0.16
Total Non-Current Liabilities	23.03	30.60	30.16	2.65	0.73

CURRENT LIABILITIES
Short Term Borrowings	9.42	8.76	7.19	2.07	0.33
Trade Payables	9.44	5.97	8.19	4.52	3.90
Other Current Liabilities	2.79	1.43	3.28	3.37	2.37
Short Term Provisions	0.04	0.03	0.02	0.42	0.19
Total Current Liabilities	21.69	16.18	18.68	10.38	6.79

Total Capital And Liabilities	207.69	191.94	170.94	55.28	41.34

ASSETS
NON-CURRENT ASSETS
Tangible Assets	104.63	94.97	80.48	18.67	14.42
Intangible Assets	0.03	0.04	0.07	1.47	0.07
Capital Work-In-Progress	12.38	8.34	16.63	0.00	0.00
Intangible Assets Under Development	0.49	0.43	0.29	0.00	0.00
Fixed Assets	117.52	103.78	97.47	20.14	14.50
Non-Current Investments	0.08	0.08	0.08	0.07	0.05
Long Term Loans And Advances	0.00	0.00	0.00	1.06	0.72
Other Non-Current Assets	4.22	10.50	3.18	0.20	0.27
Total Non-Current Assets	121.82	114.37	100.73	21.46	15.53


CURRENT ASSETS
Current Investments	12.45	18.26	4.66	3.00	4.00
Inventories	24.01	22.02	24.99	6.41	6.51
Trade Receivables	32.57	22.27	20.33	17.79	9.72
Cash And Cash Equivalents	13.48	10.03	16.26	2.33	1.00
Short Term Loans And Advances	0.00	0.00	0.00	0.98	2.51
OtherCurrentAssets	3.36	5.00	3.96	3.32	2.07
Total Current Assets	85.86	77.58	70.20	33.82	25.81

Total Assets	207.69	191.94	170.94	55.28	41.34

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	1.66	5.21	4.97	0.00	0.00

BONUS DETAILS
Bonus Equity Share Capital	3.03	3.03	3.04	0.00	0.00

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.08	0.08	0.08	0.07	0.05

CURRENT INVESTMENTS
Current Investments Quoted Market Value	12.45	18.26	4.66	0.00	0.00
Current Investments Unquoted Book Value	0.00	0.00	0.00	3.00	4.00

Source: Financial statements as reported by the company.